<DOC>
	<DOCNO>NCT01814852</DOCNO>
	<brief_summary>This prospective , randomize , double-blind clinical study assess safety efficacy treatment perform Renova ( LI-ESWT ) symptomatic ED patient .</brief_summary>
	<brief_title>Low Intensity Extracorporeal Shockwave Therapy ( LI-ESWT ) 'Renova ' Patients With Erectile Dysfunction</brief_title>
	<detailed_description>This prospective , randomize , double-blind clinical study compare safety efficacy treatment perform Renova ( LI-ESWT ) symptomatic ED patient safety efficacy control sham patient . Patients randomize 1:1 ratio Renova sham control group .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Good general health Vasculogenic ED least 6 month International Index Erectile Function 6 ( IIEFEF ) 11 25 Positive response PDE5I ( able penetrate demand , Responders ) Negative response PDE5I ( unable penetrate demand even maximum PDE5I dosage , Nonresponders ) Stable heterosexual relationship 3 month Psychogenic ED Neurological pathology Hormonal pathology Past radical prostatectomy Recovering cancer last 5 year Any unstable medical , psychiatric , spinal cord injury penile anatomical abnormality Clinically significant chronic hematological disease Antiandrogens , oral injectable androgen Radiotherapy pelvic region</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Low Intensity Shockwave</keyword>
	<keyword>Extracorporeal shockwave therapy</keyword>
	<keyword>Erectile dysfunction</keyword>
</DOC>